Загрузка видео...

Не удалось загрузить видео

На главную

Cancer Breakthrough: Two Cheap Generic Drugs. One Stunning Combination. Ivermectin and mebendazole — both FDA-approved, both widely available, both dirt cheap — are showing results in solid organ cancers that expensive chemotherapy protocols can't match on safety alone. Large-scale randomized trials are the next step. The data is already...

22,830 просмотров • 3 месяцев назад •via X (Twitter)

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

🚨 Why Ivermectin Shows So Much Promise Against Cancer (But Almost No Human Trials) Ivermectin doesn’t just have one or two effects on cancer; it has over a dozen different mechanisms of action. Here are some of the key ones: - Kills cancer stem cells (the cells chemotherapy often misses) - Reverses multidrug resistance, making cancer cells more sensitive to chemotherapy again - Acts as a radiosensitizer, helping radiation work better - Inhibits angiogenesis (stops tumors from forming new blood vessels) - Blocks matrix metalloproteinases, which helps prevent cancer from spreading and metastasizing Despite hundreds of preclinical studies showing these effects, there are almost no large human trials. Only small case reports exist (for example, some leukemia patients showing remission). Why? Because Ivermectin has been off-patent since the 1990s. It’s a cheap, generic drug. When there’s no money to be made, tragically, large-scale research rarely happens, especially in oncology. This is the same story with many other repurposed drugs. Promising lab results exist, but without financial incentive, human trials rarely move forward. That’s why so many patients are now doing their own research into these options. If you're exploring Ivermectin or Fenbendazole protocols, many people are choosing clean, pharmaceutical-grade versions from PharmacyinUSA. Save this for reference. #Ivermectin #CancerResearch #RepurposedDrugs #Fenbendazole #CancerStemCells

PharmacyinUSA

11,650 просмотров • 15 дней назад